SPIRE – combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial

BACKGROUND: Urothelial bladder cancer (UBC) accounts for 10,000 new diagnoses and 5000 deaths annually in the UK (Cancer Research UK, http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bladder-cancer, Cancer Research UK, Accessed 26 Mar 2018). Cisplatin-b...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Trials
Main Authors: Crabb, Simon, Danson, Sarah J., Catto, James W. F., McDowell, Cathy, Lowder, James N., Caddy, Joshua, Dunkley, Denise, Rajaram, Jessica, Ellis, Deborah, Hill, Stephanie, Hathorn, David, Whitehead, Amy, Kalevras, Mihalis, Huddart, Robert, Griffiths, Gareth
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5883402/
https://ncbi.nlm.nih.gov/pubmed/29615077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-018-2586-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares